his session will serve as an introduction to the topic of personalized medicine from the perspective of major stakeholders including: scientists, physicians, patients and their advocates, community groups and media professionals. We’ll begin with an introduction to the basic concepts and efforts in this area, followed by a discussion of information resources to serve stakeholder groups including relevant clinical, consumer health, and advocacy and policy resources. Various initiatives by government agencies, the commercial sector and academia will be discussed, including: Genetics Home Reference, 23andMe, PatientsLikeMe, and more.
